Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Market Videos
Currencies
International
Treasury & Bonds
Search InvestCenter
Recent Quotes
My Watchlist
Indicators
Roche Holding AG Basel American Depositary Shares (OP: RHHBY)
62.45 USD  +0.01 (+0.02%)
Official Closing Price  /  Updated: 5:20 PM EDT, Jun 18, 2013  /  Add to My Watchlist      
View: Quote News Research
Press releases about Roche Holding AG Basel American Depositary Shares
 
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Uncovering cancer in today's anatomic pathology lab
June 04, 2013
VENTANA digital pathology software: finding and analyzing cancer with a click Read More
from PR Newswire
Ventana and Barco revolutionize digital pathology viewing experience
June 03, 2013
from PR Newswire
Seattle Genetics Highlights ADCETRIS® (Brentuximab Vedotin) Frontline HL and MTCL Clinical Development Programs and Antibody-Drug Conjugate (ADC) Collaborator Data at ASCO Annual Meeting
June 02, 2013
from Business Wire News Releases
Genentech’s Medicine Avastin Plus Chemotherapy Improved Survival in Women with Advanced Cervical Cancer, Compared to Chemotherapy Alone
June 02, 2013
from Business Wire News Releases
Genentech Announces Final Phase III Study Results of Avastin Plus Radiotherapy and Chemotherapy in People with an Aggressive Form of Brain Cancer
June 01, 2013
from Business Wire News Releases
Genentech’s Obinutuzumab (GA101) Significantly Reduced the Risk of Disease Progression or Death in People with One of the Most Common Forms of Blood Cancer
May 15, 2013
from Business Wire News Releases
New Roche Award for Antibody-based Cancer Therapy Research
May 15, 2013
from PR Newswire
Genentech to Present Important New Data Reflecting Broad Cancer Pipeline at ASCO
May 15, 2013
from Business Wire News Releases
FDA Approves Tarceva (Erlotinib) Tablets and Cobas EGFR Mutation Test for Specific Type of Lung Cancer
May 14, 2013
from Business Wire News Releases
FDA Approves ACTEMRA® for Children Living with a Rare Form of Arthritis
April 30, 2013
from Business Wire News Releases
News and Analysis Reports On: (OTC:RHHBY), (Pink:NSRGY)
April 22, 2013
from SBWire Direct - Latest Press Releases
Evotec Extends Drug Discovery Alliance With Genentech
April 22, 2013
from GlobeNewswire News Releases
Active Runners on Mid-Day: (OTC:RHHBY), (Pink:NSRGY)
April 19, 2013
from SBWire Direct - Latest Press Releases
Daily Trend Analysis Report On: (OTCQX: RHHBY), (OTC Pink: NSRGY)
April 19, 2013
from SBWire Direct - Latest Press Releases
Daily Trend Analysis Report On: (OTC:RHHBY), (Pink:NSRGY)
April 19, 2013
from SBWire Direct - Latest Press Releases
PetroBakken Energy Ltd. and Roche Holding Ltd. Report: (Pink:PBKEF), (OTC:RHHBY)
April 18, 2013
from SBWire Direct - Latest Press Releases
Harbor Island Development Corp and Roche Holding AG News: (OTC:HIDC), (OTC:RHHBY)
April 16, 2013
from SBWire Direct - Latest Press Releases
Free Research Reports on IART, MSFT, RHHBY and ROST Issued by the Bedford Report
April 12, 2013
Note to Editors: The Following Is an Investment Opinion Being Issued by the Equity News Circuit Read More
from Marketwired News Releases
Trulan Resources Inc. & Roche Holding AG Trend Analysis Report: (Pink:TRLR), (OTC:RHHBY)
April 11, 2013
from SBWire Direct - Latest Press Releases
InVivo Therapeutics Holdings & Roche Holding AG News: (OTC:NVIV), (OTC:RHHBY)
April 09, 2013
from SBWire Direct - Latest Press Releases
Roche and Isis Pharmaceuticals form alliance for Huntington's disease
April 08, 2013
from PR Newswire
Daily Commentary & Reports For: (Pink:DEMBF), (OTC:RHHBY)
April 01, 2013
from SBWire Direct - Latest Press Releases
Roche Holding AG & Hokutou Holdings International News: (OTC:RHHBY), (Pink:HKTU)
March 11, 2013
from SBWire Direct - Latest Press Releases
Tucson Symposium attracts over 450 global scientists focused on personalized healthcare
March 08, 2013
from PR Newswire
Ventana and Biocare Medical sign p63 license agreement to aid in the differential diagnosis of benign and malignant prostate lesions
February 26, 2013
from PR Newswire
Phase III Results Showed omalizumab Significantly Reduced Disease Severity in Patients with a Chronic Form of Hives who Failed Standard Therapy
February 24, 2013
from Business Wire News Releases
FDA Approves Genentech’s Kadcyla (Ado-Trastuzumab Emtansine), the First Antibody-Drug Conjugate for Treating HER2-Positive Metastatic Breast Cancer
February 22, 2013
from Business Wire News Releases
Which Cancer-Focused Stocks Are Posting Significant Gains: (OTCQX: RHHBY), (OTCQB: ADXS)
February 19, 2013
from SBWire Direct - Latest Press Releases
Roche and Chiasma announce collaboration to develop and commercialize Chiasma's Octreolin® for acromegaly and neuroendocrine tumors
February 18, 2013
from PR Newswire
RQx Pharmaceuticals and Genentech Enter Drug Discovery Collaboration to Develop Novel Drug Compounds
February 12, 2013
from PR Newswire
< Previous 1 2 3 4 5 6 7 8 9
...
15 16 Next >
Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here

WHAT'S POPULAR IN THE VILLE

1
The QE Carry Trade Is Imploding Right Under Everyone's Noses
Vince Foster
2
What Now, Mr. Bernanke? Traders Position Into the FOMC Rate Decision
Todd Harrison
3
Immunotherapy: Four Companies on the Verge of Cancer-Treatment Breakthroughs
TM Meyer
4
In Insider Trading, Phillip Frost Increases Stake in Opko Health Inc. and Larry Page Sells Shares of Google Inc
Jonathan Moreland
5
Why Apple Inc. Can't Be Forgiven for iOS 7
Mike Schuster